Presentation is loading. Please wait.

Presentation is loading. Please wait.

Special Populations: Pediatrics Arthur G. Roberts.

Similar presentations


Presentation on theme: "Special Populations: Pediatrics Arthur G. Roberts."— Presentation transcript:

1 Special Populations: Pediatrics Arthur G. Roberts

2 Is there a difference in blood flow (Q) between an athlete and non-athlete? Blood flow increases during exercise. At rest, blood flow is similar to non-athletes, except that it takes less beats/min to push the same amount of blood.

3 Review: Creatine Clearance Used to measure renal function and estimate glomulerular filtration rate (GFR) Creatine- breakdown product of creatinine, part of muscle Measure – blood and urine

4 Age Classifications Neonate- to 1 month post utero Infant- 1 month to 2 years Child- 2 and 12 years Pre-adolescent and adolescent- 13 to 17 years Adult- >18 years of age

5 Absorption Affected Gastric acid secretion Bile salt formation Gastric emptying time Intestinal motility Bowel length and effective absorptive surface Microbial flora

6 Effects on Absorption decrease in gastric pH – neonates, infants, young children – pH = 6-8 at birth (vaginal delivery, amniotic fluid) – increases to body weight ~2-3 years increase of basic drugs – penicillin decrease of weakly acidic drugs – phenytoin, phenobarbital

7 Effects on Absorption decrease gastric and intestinal motility (neonates and infants) – Peristalsis absent in first 2-4 days – Adult values reached in in 6-8 months – Prolonged diarrheal episodes may contribute decrease bile acids by 50% (neonates) – impaired absorption of lipid solubile drugs or vitamins.  -glucuronidase activity increases (breast milk)

8 Effects of Distribution: Body Composition

9 Effects on Distribution: Blood Volume Premature infants- 98 mL/kg At 1 year- 86 mL/kg > 1 year- 77 mL kg

10 Effects on Distribtuion Plasma Protein Binding – reduced Albumin (bilirubin and various drugs) Newborn- 3.1 g/dL (66% of adult) 1-3 years- 3.8 g/dL 4-6 years- 4.4 g/dL >7 years- 4.7 g/dL reduced affinity increased V d – reduced  -1-acid glycoprotein (orosomucoid) increased V d of basic drugs

11 Metablism and Elimination Liver metabolism – All enzymes, but activity reduced – Phase I (20-70%) of adult (neonate) reduced hydroxylation and N-demethylation capacity reduction the same increased methylation – Phase II reaches adult values in 3-4 years reduced conjugation – UGTs- chloramphenicol-”gray baby syndrome”

12 Metabolism and Elimination: Renal Clearance Creatine Clearance – (1 day)- 18 mL/min/1.73 m 2 – (6 days)- 36 mL/min/1.73 m 2 – (1-5 months) – 70 mL/min/1.73 m 2 – (6-11 months) – 100 mL/min/1.73 m 2 – (adult)-112 mL/min/1.73 m 2

13 Metabolism and Elimination: Renal Clearance Decreased renal function 20-40% of adult Decreased glomerular filtration rate – ~40 mL/min/1.73 m 2 (neonate) premature infants even lower Decreased Tubular Secretion and transporter- mediated Reabsorption Increased t 1/2, increase dosing interval

14 Estimating GFR (Creatine Clearance): Schwartz equations k = 0.33 in preemie infants k= 0.45 in infants to 1 year k = 0.55 to 13 years of age and female >13 years k=0.70 males >13 years http://www.pharmacologyweekly.com/app/medical-calculators/pediatric-gfr-calculator- renal-function

15 What the hell is 1.73 m 2 ? normalization refers to standardized body surface area of a 70 kg man – from 8 children, 7 adults in 1928 – areas of mean and women age 25 prior to actuarial tables

16 Aminoglycosides (Antibiotic) Streptomycin Gram-negative antibacterial therapeutic agent Examples Escherichia Coli (E. coli) Salmonella Shigella

17 Aminoglycosides: Baby’s Reaction Neonates – increased V d (0.5-0.6 L/kg) (dosage?) – increased t 1/2 (dosing interval?) Infants and children – increased V d (0.4-0.5 L/kg) (dosage?) – t 1/2 normalizes (dosing interval) Adults – V d (0.25-0.35 L/kg) – t 1/2 (Streptomycin) = 3 hours – dosing interval = 8-12 hours http://www.globalrph.com/aminoglycosides.htm

18 Aminoglycosides: Cystic Fibrosis Cystic fibrosis transmembrane conductance regulator (CFTR)

19 Aminoglycosides: Cystic Fibrosis Increased Vd – increased lean body mass/kg – increased tissue binding 25% Increased Cl, shorter t 1/2 (GFR) dosing? and dosing interval?

20 Vancomycin

21 Neonates – Increased Vd (0.75 L/kg) adult 0.62 L/kg – Increased T 1/2 6-11 hours adults 4-6 hours Infants and children – Clearance 2-3x higher compared to adults – t 1/2 : 3-4 hours in infants – t 1/2 :2-3 hours in children

22 Digoxin (Lanoxin) Cardiomyocyte TN-C = Troponin C Foxglove known since the middle ages Control Heart Rate

23 Digoxin Neonates – Decreased Cl and Vd – Digoxin-like immunoreactive substance (DLIS) associated with cardiomyopathy structure similar to digoxin interferes with therapy baseline concentration may be required Infants – Increased Vd 11.9 L/kg Adult Vd 6L/kg

24 Digoxin Dosing

25 Theophylline caffeine PDE=Phosphodiesterase PKA=Protein Kinase A

26 Theophylline Indications in Pediatrics – Asthma – Premature apnea/bradycardia – Bronchopulmonary dysplasia Neonates – increased Vd, decreased Cl – lower loading and maintenance doses Children (1-4 years old) – increased Cl

27 Dosing


Download ppt "Special Populations: Pediatrics Arthur G. Roberts."

Similar presentations


Ads by Google